← Evidence library

BIB_168

Sarnaik AA et al. Lifileucel, a tumor-infiltrating lymphocyte therapy, in metastatic melanoma. J Clin Oncol 2021;39(24):2656–2666 + 2024 follow-up. PMID 33979196. CR ~7%, ORR ~31% in ICI-progressed advanced melanoma. FDA approval Feb 2024; EMA + NHS pending. [Tasks: 17, 18, 19a] Tier: 2 Grade: A Retrieved: 2026-05-07

Evidence grade

A

Tier

2

Cited by tasks

17, 18, 19a

Identifiers

PMID:33979196

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_168/findings.md (research corpus). This page is a short context summary — not individualised medical advice.